1 |
Simon, R., Freidlin, B., Rubinstein, L., Arbuck, S. G., Collins, J. and Christian, M. C. (1997). Accelerated titration designs for phase I clinical trials in oncology, Journal of the National Cancer Institute, 89, 1138-1147.
DOI
ScienceOn
|
2 |
Storer, B. E. (1989). Design and analysis of phase I clinical trials, Biometrics, 45, 925-937.
DOI
ScienceOn
|
3 |
강승호(2002). 1상 임상실험에서 수정된 CRM에 대한 연구, <응용통계연구>, 15, 323-336.
|
4 |
김동욱, 길순경 (2009). 제 1상임상시험의 SM, CRM, ATD에서 결정된 MTD의 정확성과 안전성비교, <한국통계학회논문집>, 16, 51-65.
|
5 |
박인혜 (1999). 제 1상 축차 임상시험의 최대 허용용량 추정법, 가톨릭대학교 의학통계학과 의학통계 전공 석사논문.
|
6 |
Ahn, C. (1998). An evaluation of phase I cancer clinical trial designs, Statistics in Medicine, 17, 1537-1549.
DOI
ScienceOn
|
7 |
Chevret, S. (1993). The continual reassessment method in cancer phaseⅠclinical trials: A simulation study, Statistics in Medicine, 12, 10930-1108.
|
8 |
Korn, E. L., Midthune, D., Chen, T. T., Rubinstein, L. V., Christian, M. C. and Simon, R. M. (1994). A comparison of two phase I trial designs, Statistics in Medicine, 13, 1799-1806.
DOI
ScienceOn
|
9 |
Dixon, W. J. and Mode, A. M. (1948). A method for obtaining and analyzing sensitivity data, Journal of the American Statistical Association, 43, 109-126.
DOI
ScienceOn
|
10 |
Goodman, S. N., Zhurak, M. L. and Piantadosi, S. (1995). Some practical improvements in the continual reassessment method for phase I studies, Statistics in Medicine, 14, 1149-1161.
DOI
ScienceOn
|
11 |
O'Quigley, J. and Chevret, S. (1991). Method for dose finding studies in cancer clinical trials: A review and results of a monte carlo study, Statistics in Medicine, 10, 1647-1664.
DOI
ScienceOn
|
12 |
O'Quigley, J., Pepe, M. and Fisher, M. (1990). Continual reassessment method: A practical design for phase I clinical trials in cancer, Biometrics, 46, 33-48.
DOI
ScienceOn
|
13 |
O'Quigley, J. and Shen, L. Z. (1996). Continual reassessment method: A likelihood approach, Biometrics, 52, 163-174.
|